BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11787621)

  • 1. Tyrosine-hydroxylase immunoreactive cells in the rat striatum following treatment with MPP+.
    O'Byrne MB; Bolam JP; Hanley JJ; Tipton KF
    Adv Exp Med Biol; 2000; 483():369-74. PubMed ID: 11787621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrastriatal infusion of the Parkinsonian neurotoxin, MPP(+), induces damage of striatal cell nuclei in Sprague-Dawley rats.
    Banerjee R; Sreetama S; Saravanan KS; Chandra G; Nath De S; Mohanakumar KP
    J Chem Neuroanat; 2006 Dec; 32(2-4):90-100. PubMed ID: 16822645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tyrosine hydroxylase by a dopamine neurotoxin, 1-methyl-4-phenylpyridinium ion: depletion of allostery to the biopterin cofactor.
    Maruyama W; Naoi M
    Life Sci; 1994; 55(3):207-12. PubMed ID: 7911964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptotic mode of cell death in substantia nigra following intranigral infusion of the parkinsonian neurotoxin, MPP+ in Sprague-Dawley rats: cellular, molecular and ultrastructural evidences.
    Banerjee R; Sreetama S; Saravanan KS; Dey SN; Mohanakumar KP
    Neurochem Res; 2007 Jul; 32(7):1238-47. PubMed ID: 17401660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic neurotoxins require excitotoxic stimulation in organotypic cultures.
    Kress GJ; Reynolds IJ
    Neurobiol Dis; 2005 Dec; 20(3):639-45. PubMed ID: 15996475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nigral and striatal comparative study of the neurotoxic action of 1-methyl-4-phenylpyridinium ion: involvement of dopamine uptake system.
    Santiago M; Machado A; Cano J
    J Neurochem; 1996 Mar; 66(3):1182-90. PubMed ID: 8769882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MPP(+) injection into rat substantia nigra causes secondary glial activation but not cell death in the ipsilateral striatum.
    Canudas AM; Friguls B; Planas AM; Gabriel C; Escubedo E; Camarasa J; Camins A; Pallàs M
    Neurobiol Dis; 2000 Aug; 7(4):343-61. PubMed ID: 10964606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of tyrosine hydroxylase in rat striatum by 1-methyl-4-phenylpyridinium ion (MPP+).
    Ozaki N; Nakahara D; Mogi M; Harada M; Kiuchi K; Kaneda N; Miura Y; Kasahara Y; Nagatsu T
    Neurosci Lett; 1988 Feb; 85(2):228-32. PubMed ID: 2897647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and immunocytochemical changes induced by intrastriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system: evidence for cell death in the substantia nigra.
    Ichitani Y; Okamura H; Nakahara D; Nagatsu I; Ibata Y
    Exp Neurol; 1994 Dec; 130(2):269-78. PubMed ID: 7867756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-methyl-4-phenylpyridinium (MPP+) decreases mitochondrial oxidation-reduction (REDOX) activity and membrane potential (Deltapsi(m)) in rat striatum.
    Nakai M; Mori A; Watanabe A; Mitsumoto Y
    Exp Neurol; 2003 Jan; 179(1):103-10. PubMed ID: 12504872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic dendrites in the pars reticulata of the rat substantia nigra and their striatal input. Combined immunocytochemical localization of tyrosine hydroxylase and anterograde degeneration.
    Wassef M; Berod A; Sotelo C
    Neuroscience; 1981; 6(11):2125-39. PubMed ID: 6120482
    [No Abstract]   [Full Text] [Related]  

  • 12. A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway.
    Gomes MZ; Raisman-Vozari R; Del Bel EA
    Brain Res; 2008 Apr; 1203():160-9. PubMed ID: 18313645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin attenuates MPP+-induced neurodegeneration and glutathione impairment in the nigrostriatal dopaminergic pathway.
    Chen ST; Chuang JI; Hong MH; Li EI
    J Pineal Res; 2002 May; 32(4):262-9. PubMed ID: 11982797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic selegiline administration transiently decreases tyrosine hydroxylase activity and mRNA in the rat nigrostriatal pathway.
    Vrana SL; Azzaro AJ; Vrana KE
    Mol Pharmacol; 1992 May; 41(5):839-44. PubMed ID: 1350320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-methyl-4-phenylpyridinium and an endogenously formed analog, N-methylated beta-carbolinium, inhibit striatal tyrosine hydroxylation in freely moving rats.
    Matsubara K; Idzu T; Kobayashi Y; Nakahara D; Maruyama W; Kobayashi S; Kimura K; Naoi M
    Neurosci Lett; 1995 Oct; 199(3):199-202. PubMed ID: 8577397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of and 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity against dopaminergic neurons in coculture of rat mesencephalon with their target on non-target regions.
    Akaneya Y; Takahashi M; Hatanaka H
    Neurosci Res; 1995 Aug; 23(1):55-63. PubMed ID: 7501301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrapallidal injection of 6-hydroxydopamine induced changes in dopamine innervation and neuronal activity of globus pallidus.
    Bouali-Benazzouz R; Tai CH; Chetrit J; Benazzouz A
    Neuroscience; 2009 Dec; 164(2):588-96. PubMed ID: 19628021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal tyrosine hydroxylase immunoreactive neurons are induced by L-dihydroxyphenylalanine and nerve growth factor treatment in 6-hydroxydopamine lesioned rats.
    Jollivet C; Montero-Menei CN; Venier-Julienne MC; Sapin A; Benoit JP; Menei P
    Neurosci Lett; 2004 May; 362(2):79-82. PubMed ID: 15193758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine hydroxylase mRNA expression by dopaminergic neurons in culture: effect of 1-methyl-4-phenylpyridinium treatment.
    Beck KD; Knusel B; Pasinetti G; Michel PP; Zawadzka H; Goldstein M; Hefti F
    J Neurochem; 1991 Aug; 57(2):527-32. PubMed ID: 1677030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colocalization of tyrosine hydroxylase and GAD65 mRNA in mesostriatal neurons.
    González-Hernández T; Barroso-Chinea P; Acevedo A; Salido E; Rodríguez M
    Eur J Neurosci; 2001 Jan; 13(1):57-67. PubMed ID: 11135004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.